ISRAEL: RESPERATE DEVICE TO BE MARKETED.(in United States)(Brief Article)

IPR Strategic Business Information Database, July, 2002

Medical devices company InterCure said it has received U.S. Food and Drug Administration (FDA) approval to market its RESPeRATE device to lower high blood pressure, GLOBES reported. The device does not use drugs, and will be marketed in the U.S. without a doctor's prescription. InterCure will start marketing the device in the U.S. this week to consumers for $299.